Drug intelligence / Profile preview

Triple Lipid Restore 2:4:2

Development stage: Unknown
Lead developer: SkinCeuticals
Administration: Topical

Overview

Triple Lipid Restore 2:4:2 is a corrective anti-aging cream developed by SkinCeuticals (a L'Oréal brand) designed to address the age-related depletion of essential skin lipids. The formulation contains a patented ratio of 2% pure ceramides 1 and 3, 4% natural cholesterol, and 2% fatty acids. By replenishing these lipids, the product aims to restore the skin's moisture barrier, enhance natural repair processes, and improve visible signs of aging such as skin smoothness, laxity, and radiance. In clinical research, it has been evaluated for its ability to improve skin barrier function and patient satisfaction in individuals with rosacea.

Brand names: SkinCeuticals Triple Lipid Restore 2:4:2
Other names: Triple Lipid Restore

Targets

Stratum corneum lipid matrix

Beyond the preview

Go deeper on Triple Lipid Restore 2:4:2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triple Lipid Restore 2:4:2.

Explore the full profile